Patent · US Expired

Use of stabilized oligonucleotides for preparing a medicament with antitumor activity

US7108844B2 · kind B2 · utility

15Cited by

18References

9Claims

0Family size

Assignees

ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventor

Antoine Carpentier · Paris, FR

Key dates

Filing date	Sep 28, 2001
Grant date	Sep 19, 2006
Priority date	—
Expiry date	Nov 3, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H21/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns the use of stabilized oligonucleotides comprising at least an octamer motif of the type: 5′-purine-purine-CG-pyrimidine-pyrimidine-X1X2-3′ wherein the pair X1-X2- is AT, AA, CT or TT, for preparing a medicine with antitumor activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.